Holocene Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-81,857
| Closed | -$78.8M | – | 823 |
|
|
2024
Q1 | $78.8M | Sell |
81,857
-278,623
| -77% | -$268M | 0.29% | 108 |
|
|
2023
Q4 | $317M | Buy |
360,480
+182,727
| +103% | +$160M | 1.23% | 6 |
|
|
2023
Q3 | $146M | Buy |
177,753
+16,891
| +11% | +$13.9M | 0.64% | 46 |
|
|
2023
Q2 | $116M | Buy |
160,862
+32,613
| +25% | +$23.4M | 0.49% | 65 |
|
|
2023
Q1 | $105M | Buy |
128,249
+56,073
| +78% | +$46.1M | 0.52% | 65 |
|
|
2022
Q4 | $52.1M | Buy |
+72,176
| New | +$52.1M | 0.32% | 103 |
|
|
2021
Q1 | – | Sell |
-1,498
| Closed | -$724K | – | 909 |
|
|
2020
Q4 | $724K | Buy |
+1,498
| New | +$724K | ﹤0.01% | 578 |
|
|
2020
Q3 | – | Sell |
-122,952
| Closed | -$76.7M | – | 754 |
|
|
2020
Q2 | $76.7M | Buy |
+122,952
| New | +$76.7M | 0.67% | 46 |
|
|
2018
Q2 | – | Sell |
-752
| Closed | -$259K | – | 690 |
|
|
2018
Q1 | $259K | Sell |
752
-1,613
| -68% | -$556K | 0.01% | 422 |
|
|
2017
Q4 | $889K | Buy |
+2,365
| New | +$889K | 0.02% | 213 |
|